Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1

Abstract Endothelin-1 (ET-1) is involved in the pathogenesis of cardiac and renal diseases, and in the progression of tumour growth in cancer, but current diagnosis and treatment remain inadequate. Peptides derived from the 212 amino acid precursor preproendothelin-1 (ppET-1) may have utility as bio...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Jale Yuzugulen, Julie A. Douthwaite, Elizabeth G. Wood, Inmaculada C. Villar, Nimesh S. A. Patel, James Jegard, Hubert Gaertner, Irène Rossitto-Borlat, Keith Rose, Oliver Hartley, Pedro R. Cutillas, Amrita Ahluwalia, Roger Corder
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2017
Materias:
R
Q
Acceso en línea:https://doaj.org/article/c88405d4ef9a4272ab9b01473d274a6f
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:c88405d4ef9a4272ab9b01473d274a6f
record_format dspace
spelling oai:doaj.org-article:c88405d4ef9a4272ab9b01473d274a6f2021-12-02T15:18:52ZCharacterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-110.1038/s41598-017-05365-22045-2322https://doaj.org/article/c88405d4ef9a4272ab9b01473d274a6f2017-07-01T00:00:00Zhttps://doi.org/10.1038/s41598-017-05365-2https://doaj.org/toc/2045-2322Abstract Endothelin-1 (ET-1) is involved in the pathogenesis of cardiac and renal diseases, and in the progression of tumour growth in cancer, but current diagnosis and treatment remain inadequate. Peptides derived from the 212 amino acid precursor preproendothelin-1 (ppET-1) may have utility as biomarkers, or cause biological effects that are unaffected by endothelin receptor antagonists. Here, we used specific immunoassays and LC-MS/MS to identify NT-proET-1 (ppET-1[18–50]), Endothelin-Like Domain Peptide (ELDP, ppET-1[93–166]) and CT-proET-1 (ppET-1[169–212]) in conditioned media from cultured endothelial cells. Synthesis of these peptides correlated with ET-1, and plasma ELDP and CT-proET-1 were elevated in patients with chronic heart failure. Clearance rates of NT-proET-1, ELDP and CT-proET-1 were determined after i.v. injection in anaesthetised rats. CT-proET-1 had the slowest systemic clearance, hence providing a biological basis for it being a better biomarker of ET-1 synthesis. ELDP contains the evolutionary conserved endothelin-like domain sequence, which potentially confers biological activity. On isolated arteries ELDP lacked direct vasoconstrictor effects. However, it enhanced ET-1 vasoconstriction and prolonged the increase in blood pressure in anaesthetised rats. ELDP may therefore contribute to disease pathogenesis by augmenting ET-1 responses.Jale YuzugulenJulie A. DouthwaiteElizabeth G. WoodInmaculada C. VillarNimesh S. A. PatelJames JegardHubert GaertnerIrène Rossitto-BorlatKeith RoseOliver HartleyPedro R. CutillasAmrita AhluwaliaRoger CorderNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 7, Iss 1, Pp 1-15 (2017)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Jale Yuzugulen
Julie A. Douthwaite
Elizabeth G. Wood
Inmaculada C. Villar
Nimesh S. A. Patel
James Jegard
Hubert Gaertner
Irène Rossitto-Borlat
Keith Rose
Oliver Hartley
Pedro R. Cutillas
Amrita Ahluwalia
Roger Corder
Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1
description Abstract Endothelin-1 (ET-1) is involved in the pathogenesis of cardiac and renal diseases, and in the progression of tumour growth in cancer, but current diagnosis and treatment remain inadequate. Peptides derived from the 212 amino acid precursor preproendothelin-1 (ppET-1) may have utility as biomarkers, or cause biological effects that are unaffected by endothelin receptor antagonists. Here, we used specific immunoassays and LC-MS/MS to identify NT-proET-1 (ppET-1[18–50]), Endothelin-Like Domain Peptide (ELDP, ppET-1[93–166]) and CT-proET-1 (ppET-1[169–212]) in conditioned media from cultured endothelial cells. Synthesis of these peptides correlated with ET-1, and plasma ELDP and CT-proET-1 were elevated in patients with chronic heart failure. Clearance rates of NT-proET-1, ELDP and CT-proET-1 were determined after i.v. injection in anaesthetised rats. CT-proET-1 had the slowest systemic clearance, hence providing a biological basis for it being a better biomarker of ET-1 synthesis. ELDP contains the evolutionary conserved endothelin-like domain sequence, which potentially confers biological activity. On isolated arteries ELDP lacked direct vasoconstrictor effects. However, it enhanced ET-1 vasoconstriction and prolonged the increase in blood pressure in anaesthetised rats. ELDP may therefore contribute to disease pathogenesis by augmenting ET-1 responses.
format article
author Jale Yuzugulen
Julie A. Douthwaite
Elizabeth G. Wood
Inmaculada C. Villar
Nimesh S. A. Patel
James Jegard
Hubert Gaertner
Irène Rossitto-Borlat
Keith Rose
Oliver Hartley
Pedro R. Cutillas
Amrita Ahluwalia
Roger Corder
author_facet Jale Yuzugulen
Julie A. Douthwaite
Elizabeth G. Wood
Inmaculada C. Villar
Nimesh S. A. Patel
James Jegard
Hubert Gaertner
Irène Rossitto-Borlat
Keith Rose
Oliver Hartley
Pedro R. Cutillas
Amrita Ahluwalia
Roger Corder
author_sort Jale Yuzugulen
title Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1
title_short Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1
title_full Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1
title_fullStr Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1
title_full_unstemmed Characterisation of preproendothelin-1 derived peptides identifies Endothelin-Like Domain Peptide as a modulator of Endothelin-1
title_sort characterisation of preproendothelin-1 derived peptides identifies endothelin-like domain peptide as a modulator of endothelin-1
publisher Nature Portfolio
publishDate 2017
url https://doaj.org/article/c88405d4ef9a4272ab9b01473d274a6f
work_keys_str_mv AT jaleyuzugulen characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT julieadouthwaite characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT elizabethgwood characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT inmaculadacvillar characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT nimeshsapatel characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT jamesjegard characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT hubertgaertner characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT irenerossittoborlat characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT keithrose characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT oliverhartley characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT pedrorcutillas characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT amritaahluwalia characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
AT rogercorder characterisationofpreproendothelin1derivedpeptidesidentifiesendothelinlikedomainpeptideasamodulatorofendothelin1
_version_ 1718387474752864256